ANI Pharmaceuticals (ANIP) ROE US GAAP (year values) |
||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | |||
| ROE, % | ? | -11.9% | -14.1% | 4.10% | -4.32% | 14.5% | 15.9% | |
| Changes by years, y/y, % | 0pp | -2pp | +18pp | -8pp | +19pp | |||
ANI Pharmaceuticals. ROE, %
ANI Pharmaceuticals. ROE, changes, pp
ANI Pharmaceuticals (ANIP) ROE US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| ROE, % | ? | -4.75% | -2.21% | 7.53% | 14.0% | 15.9% | 15.9% | |
| Changes by years, y/y, % | -12pp | -8pp | +9pp | +18pp | +21pp | |||
| Changes by quarters, q/q, % | 0pp | +3pp | +10pp | +6pp | +2pp | |||